Immix Biopharma
IMMX
IMMX
35 hedge funds and large institutions have $15.6M invested in Immix Biopharma in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15.91% more ownership
Funds ownership: 4.02% → 19.93% (+16%)
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.77M | |
| 2 | +$2.61M | |
| 3 | +$2.06M | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$1.24M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$908K |
Top Sellers
| 1 | -$710K | |
| 2 | -$138K | |
| 3 | -$128K | |
| 4 |
Jane Street
New York
|
-$103K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$72K |